Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAVO in Mild to Moderate Depression in Children and Adolescents
NCT05789186Phase 1Unknown
- Start
- May 2023
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Cang-ai Volatile Oil in major depressive disorder (MDD) (3 arms). Primary endpoints: Hamilton Depression Scale at 3 months, Children's Depression Inventory at 3 months and 3 more. Status: unknown.
02
Drugs
Cang-ai Volatile Oil
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05789186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05789186.